Clearstead Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
2,228
+341
| +18% | +$183K | 0.02% | 401 |
|
|
2025
Q1 | $792K | Buy |
1,887
+158
| +9% | +$66.4K | 0.01% | 461 |
|
|
2024
Q4 | $715K | Buy |
1,729
+20
| +1% | +$8.27K | 0.01% | 483 |
|
|
2024
Q3 | $863K | Buy |
1,709
+8
| +0.5% | +$4.04K | 0.01% | 444 |
|
|
2024
Q2 | $829K | Buy |
1,701
+1,587
| +1,392% | +$773K | 0.01% | 430 |
|
|
2024
Q1 | $57.3K | Sell |
114
-5
| -4% | -$2.52K | ﹤0.01% | 731 |
|
|
2023
Q4 | $66.1K | Sell |
119
-1,252
| -91% | -$695K | ﹤0.01% | 678 |
|
|
2023
Q3 | $599K | Buy |
1,371
+1,257
| +1,103% | +$550K | 0.02% | 377 |
|
|
2023
Q2 | $57.3K | Hold |
114
| – | – | ﹤0.01% | 709 |
|
|
2023
Q1 | $57K | Buy |
114
+104
| +1,040% | +$52K | ﹤0.01% | 636 |
|
|
2022
Q4 | $4.08K | Hold |
10
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q3 | $3K | Sell |
10
-1,511
| -99% | -$453K | ﹤0.01% | 1030 |
|
|
2022
Q2 | $533K | Buy |
1,521
+6
| +0.4% | +$2.1K | 0.04% | 238 |
|
|
2022
Q1 | $829K | Sell |
1,515
-194
| -11% | -$106K | 0.06% | 199 |
|
|
2021
Q4 | $1.13M | Hold |
1,709
| – | – | 0.08% | 171 |
|
|
2021
Q3 | $1.06M | Sell |
1,709
-8
| -0.5% | -$4.98K | 0.08% | 164 |
|
|
2021
Q2 | $1.08M | Sell |
1,717
-12
| -0.7% | -$7.58K | 0.08% | 161 |
|
|
2021
Q1 | $846K | Buy |
1,729
+25
| +1% | +$12.2K | 0.07% | 174 |
|
|
2020
Q4 | $852K | Buy |
+1,704
| New | +$852K | 0.08% | 163 |
|